What You Should Know:  – The U.S. health economy is at a critical juncture, defined by unchecked prices, inefficiency, and mounting political pressure for reform, according to Trilliant Health’s latest

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they’re vital for treating obesity. The post As Insurers Drop GLP-1 Coverage, Advocates Search

A company is looking for a Clinical Operations Manager to lead and support their Clinical Assistant Team and enhance clinical workflows. Key Responsibilities Supervise and manage the performance of the

TV DOCTOR Ranj Singh is bowing out of BBC’s Morning Live to be the new face of a weight loss company. The 46-year-old presenter landed a lucrative deal to promote

Antonio_Diaz/Getty Images Around one in three Australian adults (32%) has a body-mass index (BMI) of 30 or above. A further 34% has a BMI of 25 or above. Australia’s regulator

AstraZeneca AZN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. The announcement comes just days after Pfizer PFE signed a similar deal

Traditional radiofrequency devices have long been dogged by compromises—painful sessions, unwanted fat loss, a major drawback particularly in the GLP-1 era, or results that fade too fast. Cynosure Lutronic’s XERF

(MedPage Today) — Three GLP-1 receptor agonists had generally comparable cardiorenal outcomes when used in type 2 diabetes, a retrospective comparative effectiveness study indicated. Among 21,790 military veterans with diabetes,

Early findings highlight long-term influence of GLP-1s on consumer behavior

How much a stock’s price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors

Many consumers prefer convenience stores over all the other alternatives, even for their regular grocery shopping. Why? It’s simple: They have a strong presence nationwide and offer easy access and

Key Points Viking Therapeutics is nearing the finish line with a candidate for weight loss — to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates

Is fiber finally getting its day in the sun? Is RFK Jr’s anti-seed oil crusade filtering through to consumers? And have we reached peak protein? We may see a falloff

Ascletis Pharma Inc. has selected ASC-35, a once-monthly, subcutaneously administered GLP-1 receptor (GLP-1R)/GIP receptor (GIPR) dual peptide agonist, as a clinical development candidate. Ascletis expects to submit an IND application

A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with the Food and Drug Administration standards, a serious designation that could

CHERYL Fergison says she can’t lose weight on fat jabs – but is suffering BRUTAL side effects. The former EastEnders star says she’s “leaking from both ends” and has even

Weight loss medications like Ozempic and Wegovy are showing promise in treating drug and alcohol addiction. Research indicates these GLP-1 receptor agonists may reduce substance use and cravings by impacting

Eating a healthy diet can seem like a confusing and complicated task. Should I try keto, or is the real answer vegan? Cut carbs or pile on the fibre? Is

FROM nausea and hair loss to grim burps and life-threatening pancreatitis, if you’re one of the estimated million-plus fat jab fanatics, chances are you are clued up on the side

EMMA McDonald was forced to have her gallbladder removed after it started “rotting” when she took Mounjaro. Despite the horrific ordeal, the 38-year-old mum had “no regrets” after losing 8st and

Key Points You don’t want to overpay for an exchange-traded fund (ETF). You don’t want to get too aggressive with an ETF. You don’t want to forget about diversification with

It should come as no surprise that GLP-1 receptor agonists have revolutionized the management of obesity and metabolic syndrome. These drugs have shown extraordinary promise in regulating appetite, promoting weight

Since Wegovy received approval as a weight loss treatment in 2021, there has been huge demand for GLP-1 drugs. These drugs reduce hunger and suppress the “food noise” that can

“No one knows exactly what is the impact of these new [GLP-1 receptor agonist] drugs Ozempic or Mounjaro… but something is happening because protein overall became [a trend],” JBS meat

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and drug addiction. A widely used group of medications originally developed to

A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without adding side effects – in a mid-stage clinical trial,

If you’re interested in the science of healthspan and longevity, you’ve likely heard of the naked mole rat, a remarkable outlier among mammals that defies the laws of biologic aging.

Over the last couple of years, popular weight loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have revolutionized weight loss in the U.S. In a country where the Centers for

Getty Images A range of tastes and trends are expected to land in candy baskets this year. Key Takeaways Candy is expected to account for about one-third of the $13

EVERYONE talks about starting weight loss jabs – but what about stopping them? If you’re worried about the food noise roaring back with a vengeance, you’re not alone. Here, we

Abstract Aims The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) influence metabolism through strong effects on pancreatic hormone secretion but also in a pancreas-independent manner. Here,

Click in for more news from The Hill {beacon} Health Care   The Big Story  GOP turns up heat on mifepristone  Pressure is mounting from the right on the Trump

(NaturalNews) Patients on GLP?1 drugs like Ozempic, Wegovy and Mounjaro are increasingly reporting severe gastrointestinal symptomsânot merely mild nausea, bu…

GLP-1 use in HFrEF, left atrial posterior wall isolation during AF ablation, peri-device leaks for LAAO, new findings in post-cardiac surgery AF, and imaging before AF ablation are the topics

Michelle, a 42-year-old marketing executive, was scrolling through her grocery app when she saw the total: $87. A year ago, her weekly cart never dipped below $200. Chips, late-night snacks,

A North Carolina woman has been busy over the last three years, illegally obtaining weight-loss medication, administering it to people, and defrauding insurance companies of more than $87,400, the state

Gut health is one of the biggest trends of the year. It’s a catch-all term that’s been used to sell supplements, spook people about their diets and encourage disordered eating.

(MedPage Today) — Nearly half of patients prescribed a GLP-1 receptor agonist were not filling the order, with certain factors playing a role, according to a cohort study. Among nearly

Novo Nordisk NVO continues to derive the bulk of its revenue from its blockbuster semaglutide (GLP-1 RA) therapies, Wegovy for obesity and Ozempic for type II diabetes (T2D). Together, the

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Quick programming note: This newsletter will take a break

The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro more… Reuters Health Information

Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish pharma giant announced Thursday that it will acquire San Francisco-based

Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with medical

Abstract Aims Semaglutide, a GLP-1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The

A MUM who battled obesity from a young age has shared how she was eating her way toward an early grave before trying weight loss jabs. She splurged £2,000 on

With GLP-1 drugs in the mix now, a 30-something letter writer is under all new pressure from weight-obsessed parents.

With GLP-1 drugs in the mix now, a 30-something letter writer is under all new pressure from weight-obsessed parents.

PepsiCo Inc. reported on Oct. 9 third-quarter earnings that exceeded expectations, driven by healthier snacks. The company generated $23.94 billion in revenue in the quarter, outpacing its forecasted $23.86 billion.

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share

Click in for more news from The Hill {beacon} Health Care   The Big Story  CDC’s vaccine advisers plan big changes to childhood shots  The Centers for Disease Control’s (CDC)

(MedPage Today) — Welcome to Culture Clinic, MedPage Today’s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Doctors performing certain medical scans

Glucagon-like peptide-1 receptor (GLP-1R) agonists have recently emerged as powerful tools for the treatment of obesity through their ability to suppress food intake. However, their effects on non-ingestive motivated behaviors

Obesity is a major public health and economic challenge in the US, costing the health care system an estimated $173 billion annually, and the Congressional Budget Office should refine its

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal

THURSDAY, Oct. 9, 2025 — The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing metabolic and bariatric surgery from 2020 to 2024, according

Stigmatising the use of weight loss drugs is just a new form of ‘fatphobia.’ zimmytws/ Shutterstock Since Wegovy received approval as a weight loss treatment in 2021, there has been

“Consumers are starting to understand that fiber is the benefit that they need,” Pepsi CEO Ramon Laguarta said. mladenbalinovac/Getty Images PepsiCo is ramping up its fiber offerings, expecting it to

Sam’s Club pharmacies are now selling Novo Nordisk’s Ozempic and Wegovy for $499 per month, expanding consumer access to the popular GLP-1 drugs used for diabetes and weight loss. The

Eli Lilly LLY and AbbVie ABBV are large, well-established U.S. pharmaceutical companies, boasting several blockbuster drugs, robust R&D pipelines, strong market capitalization and global footprint. Both companies have a strong presence

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of more than $760 billion. It has been soaring in recent years due

SETTING her GoFundMe page live, Gemma Bartlett, 42, takes a deep breath and braces herself. Because the mum-of-one isn’t taking part in a charity run to help sick kids, or

WEIGHT loss drugs such as Ozempic and Wegovy are powerful tools for tackling obesity and lowering the risk of serious disease. Now new research suggests they could be used to

The NLRP3 inflammasome is a key mediator of innate immunity that integrates inflammatory and metabolic stress signals. Increased and/or chronic activation of this critical pathway has been implicated in obesity,

Oh, what a beautiful morning. Clear blue skies and delicious cool breezes are enveloping the Pharmalot campus, where the official mascots are bounding about the grounds chasing varmints and fending

WEIGHT loss jabs have boomed in popularity, and it seems everyone is trying to get their hands on them – even the fittest of Brits. A new wave of people

Novo Nordisk on Thursday said it would acquire Akero Therapeutics, the developer of a drug to treat the liver disease known as MASH, in a deal worth up to $5.2

Americans have developed a near-insatiable craving for protein. That’s led large food manufacturers like PepsiCo to come up with new formulas that prominently feature the popular macronutrient.  On Thursday, PepsiCo

Weight loss might often feel like a uphill journey but not everyone who wants to get rid of those extra kilos should resort to GLP-1 drugs.

A new study finds that GLP-1 weight-loss drugs such as Ozempic and Wegovy may alter PET-CT cancer scans, raising concerns about false positives and unnecessary treatment risks

Amazon Pharmacy will begin offering prescription pickup kiosks at its One Medical clinics starting in Los Angeles this December, allowing patients to collect common medications like antibiotics and inhalers without

GLP-1 medications, originally approved for diabetes, are rapidly expanding into new therapeutic territory — from cardiovascular to anti-inflammatory effects.  Norma Keller, MD, chief of cardiology at NYC Health + Hospitals/Bellevue,

It may take more than you think to prevent dangerous loss of muscle mass.

There may be fewer Medicare Advantage plans available in 2026, although the average premium is expected to decrease. Johner Images/Getty Images The Medicare open enrollment period begins on October 15

Fractyl Health Inc. has announced data on RJVA-002, a dual GIP/GLP-1 gene therapy candidate.

Bariatric surgery remains the most effective treatment for severe obesity, defined as a body mass index (calculated as weight in kilograms divided by height in meters squared) of 35 or

The clinic I’ve joined in Canada holds frequent lunchtime meetings with pharmaceutical sales representatives (PSRs). I gave up meeting PSRs in the UK years ago – regular contact alters doctors’

Starting a GLP-1 medication can feel like a whirlwind. Weight loss might be the headline benefit of GLP-1s, but these medications can also change how hungry you feel and how

The growing use of GLP-1 drugs such as Wegovy and Ozempic is reducing Americans’ sugar consumption—users spend 6% less on candy and 10% less on baked goods, Reuters reports—creating a

(MedPage Today) — Note that some links may require registration or subscription. Several California counties will require healthcare workers, and in some cases patients, to mask up during the upcoming

WEIGHT loss jabs could interfere with vital scans, potentially leading to cancer misdiagnosis, scientists say. Whether they’re taken for diabetes or weight loss, through the NHS or privately, the use

FAKE Ozempic-style pills are being sold online for rock-bottom prices as crooks try to cash in on the slimming jab craze. Dieters have been warned not to fall for dangerous

Eccogene, a clinical-stage biotech whose oral GLP-1 drug forms the backbone of AstraZeneca’s obesity pipeline, is planning an initial public offering on the Hong Kong Stock Exchange. The biotech made

‘Fonda could have taken the diabetes drug Ozempic that could have aided in her weight loss journey or she could have tried GLP-1 agonists like semaglutide and a tirzepatide.’

Huel has introduced the ‘Lite’ range, featuring low-calorie, high-protein ready-to-drink meals aimed at calorie-conscious consumers and snack-seekers. With 25 grams of protein and just 190 calories per 500 ml bottle,

By Dennis Thompson HealthDay ReporterWEDNESDAY, Oct. 8, 2025 (HealthDay News) — Many more folks fighting excess weight are using weight-loss drugs…

Patients with T2D and overweight/obesity starting GLP-1 therapy may experience a small but statistically significant increase in the risk for depression compared with those starting SGLT2 inhibitors. Medscape Medical News

Gut health is one of the biggest trends of the year. It’s a catch-all term that’s been used to sell supplements, spook people about their diets and encourage disordered eating.

Abstract Aims There is growing evidence that the GLP-1 system is implicated in alcohol and other substance use disorders, and that GLP-1-based therapies may have therapeutic relevance in alcohol use

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and {beta}-cell dysfunction. Glucagon-like peptide-1 (GLP-1) has emerged as a pivotal therapeutic target due to its

GLP-1 drugs may interfere with medical imaging, leading to unnecessary tests, researchers have found

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of

Proteomics—a term first coined in the mid-1990s—refers to the study of the complete set of proteins expressed in a cell, tissue, or organism. In contrast to genomics and transcriptomics, proteomics

Proteomics—a term first coined in the mid-1990s—refers to the study of the complete set of proteins expressed in a cell, tissue, or organism. In contrast to genomics and transcriptomics, proteomics

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of

Toronto-based digital health company Felix is expanding to offer ongoing health monitoring, aimed at increasing “longevity,” as Canadian patients seek options for preventative healthcare. Felix is part of a growing list

Explainer – The popularity of Wegovy and Ozempic has seen a flood of ads pop up. Who can you trust?

The Centers for Medicare and Medicaid Services will make an announcement on potential coverage for seniors for blockbuster GLP-1 weight loss drugs “very soon,” CMS chief Mehmet Oz said Monday.